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A selective inhibitor of cathepsin B, a derivative of E-64 (compound CA-074). and pepstatin-asialofetuin, a potent inhibitor of cathepsin D. were 
used for an in viva study of the selective role of these proteinases in lysosotnal proteolysis. Administration of compound CA-074 or pepstatin- 
asialofetuin to rats caused only a slight shift of the lysosomal density and no increase in sequestered enzymes in the autolysosomal fraction. although 
cathepsin B or D activity in the liver was markedly inhibited. These treatments also had little effect on the inhibition of the degradation of endocy- 
tosed FITC-labeled asialofetuin. In contrast, leupeptin treatment caused marked inhibition of lysosomal degradation of endogenous and exogenous 
proteins. These results suggest a small contribution of cathepsins B and D to the initiation of lysosomal proteolysis. 
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1. INTRODUCTION 
Lysosomal cathepsins B, H, L and D are major en- 
dopeptidases that are important in intracellular protein 
degradation [1,2], antigen processing [3,4], and ac- 
celerated protein turnover in various pathological con- 
ditions [5,6]. However, it is not certain which pro- 
teinase is most important in lysosomal proteolysis. 
Leupeptin and E-64, powerful inhibitors of cysteine 
proteinases, effectively inhibit the degradation of en- 
dogenous proteins in tissues [7] as well as in cultured 
cells [S], however, they do not show selective inhibition 
of cathepsins B and L in vitro or in vivo. Murata et al. 
[9] recently synthesized derivatives of E-64 in order to 
develop a specific inhibitor of cathepsin B, and 
Towatari et al. [lo] found that one of these compounds, 
CA-074, is a potent selective inhibitor of cathepsin B in 
vivo. Furuno et al. [l l] reported that pepstatin- 
asialofetuin given to rats in vivo inhibits markedly the 
activity of cathepsin D in liver. We used these two 
specific inhibitors in vivo in order to study the selective 
role of cathepsins B and D in lysosomal proteolysis. 
Abbrevrcrt/onst L, benzoylosycarbonyl; MCA, melhylcoumaryla- 
mide; BCA, bicinchoninic acid; CA-074, lV-(L-3-trons- 
propylcarbamoyloxirane-2-carbonyl)-L~i~oleucyl-L-proline; FITC. 
fluorescein isothiocyanate. 
Enzymes: cathepsin B (EC 3.4.22.1), cathepsin H (EC 3.4.22.16), 
cathepsin L (EC 3.4.22.15), cathepsin D (EC 3.4.23.5). 
Correspondence address: E Kominami. Department of 
Biochemistry, School of Medicine, Juntendo University, Hongo 
2-l-1, Bunkyo-ku, Tokyo 113, Japan. 
Our results show that cathepsins B and D do not play a 
major role in the lysosomal degradation of endogenous 
or exogenous proteins. 
2. MATERIALS AND METHODS 
2. I. Mateuals 
Arg-MCA, Z-Phe-Arg-MCA, Z-Arg-Arg-MCA, pepstatin and 
leupeptin were purchased from the Peptide Imtitute Inc., Osaka. 
Japan. Fetuin (type 3) and neuraminidase were obtamed from Sigma 
Chemical Co., and Nakalai Tesque Inc. (Kyoto, Japan), respectively. 
All other chemicals were of analytical grade. Compound CA-073, (!V- 
(L-3-t~cm.~-propyl-carbamoyloxirane-2-carbon~~l)-L-isoleucyl-L-pro- 
line) prepared by M. Murata et al. 191 was donated by Dr. Hanada, 
Taisho Pharmaceutical Co. (Saitama, Japan). 
2.2. ,Werhods 
2.2. I Anu/ytico/ procedures. Cathepsin activities were assayed with 
Z-Phe-Arg-MCA at pH 5.5 for cathepsin B and L and Arg-MCA at 
pH 6.8 for cathepsin H as substrates by the method of Barrett and 
Kirschke 121. Cathepsins L and B were measured by assay in the 
prc\ence and absence of 2 pg/ml of compound CA-074 and cathepsin 
B \+as calculated as the compound CA-074.sensitive Z-Phe-Arg-MCA 
hydrolyzing activity; the rest of the activity was regarded as cathepsin 
L activity. Assay of cathepsin D was performed with denatured 
hemoglobin as described pre\iously [IZ]. Lactic dehydrogenase and @- 
hexosaminida5e activities were determined as described previously 
[13,14]. Protein was measured by the BCA method (Pierce Chemical 
Co.) with bovine serum albumin as a standard. FITC-labeled asialofe- 
tuin in the samples was measured ftuorometrically as described 
previously [I51 with FITC-asiatofetuin from the same batch as that in- 
jected into rats as a standard. 
2.2.2. Preparuiion o.f FITC-lubeled rrsialqferuin and pepstnfin- 
usiuloferuin. Asiatofetuin was prepared by ncuraminidase treatment 
of fetuin and labeled with FITC as described previously [ 151. Coupl- 
ing of peprtatin to asiatofetuin was performed as described by Furuno 
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3. RESULTS AND DISCUSSION 
The data in Table I show that leupeprin inactivated 
cathepsins B and I. markedly and cathepsin H 
moderately, whereas CA-074 inactivated cathepsin B 
selectively. I’epstatin-asialofetuin also inactivated 
cathepsin D selectivel~~. To test the possibility that inac- 
tivation of cathepsin B is caused not by the presence of 
compound CA-074 in Iysosomes but by adsorption 01 
the inhibitor to the Iysosomal membrane, \ve subjected 
the mitochondrial-lysosomal fraction to t\\o cycles of 
freeze-thawing and then measured cathepsin B ac- 
tivities in the supernatant obtained by centrifugation at 
105 OOOxg, 60 min. Results showed that similat- 
decrease of’ cathcpsin B to that xho\\n in Table I \va$ 
observed in CA-074-treated rats (not shown). This find- 
ing suggests that compound CA-074 is present inidc of 
lysosomes. 
3.2. The ejjkt o,f proteinuse inhibitors on the 
degradation of endogenow pr0tein.s 
The administration of’ leupeptin to rats markedly in- 
creases the density of’ liver Iysosomes due to protein ac- 
cumulation [ 16,171. Li’c pre\ iously demonstrated that 
active ot- undcgraded proteins such a cytosolic en- 
rymcs, cytoskeletal proteins (myosin), and mitochon- 
drial enLyme<, arc sequestered in autolysowmes 
[ 17,181. Compound CA-071, leupeptin, and pepstatin- 
a5ialofetuin \\et-e injected into rats and the animals \verc 
hilled 1 tl latct-. The mitochoridrial~l!.soson7al ft-action 
prepared from the li\cr \\as subjected 10 Percoll densit) 
gradient analysis. The pt-ofilej of’ li\et- Iyso\omes on the 
I’ercoll den\it!. gt-adient detet-mined by measuring $ 
glucuronidasc activity at-e sho\w in Fig. 1. The 
Iysosomes of untreated rat5 5ho!v a typical br-oad denii- 
t!’ distt-ibution. Leupeptin treatment caused a marked 
shift in Iysoaomal densit!, a$ reported prwiouslq 
[16,17], but injection of’ compound CA074 ot 
pepstatin-asialofetuin resulted in a much smallet- 5tiift. 
Lactic dehydrogcnase, M hich is a cytoaolic enzyme, was 
detected in the autolysosomal fraction of leupeptin- 
tt-eated rats, but only faintly in [hat of’ compound 
CA-074. ot- pepstatin-a~ialofetuin-trc’atecl trat$, in- 
dicating that the inhibition of’ cathepsin B or cathepsin 
D b!, administration of’compound CA-074 or pcpstatin- 
asialofetuin, respectively, does not Icad to a blochage 01 
the Iy~o~omal digestion 01‘ wquestercd proteins. 
FITC-asialof‘etuin \\‘a$ injected into rats administered 
compound CA-073, leupeprin, or pcpstatin-asialofetltin 
10 min before, and the effect ofproteinase inhibirors on 
the digestion of this e\ogenou$ protein in livet 
lysosotnes ~\as esamined. IVhen 3 mg of FITC- 
aialofetuin \\a5 administered to t-atj, the trecovcry ot 
FITC in control li\er- 30 min af‘ter injection \\a~ about 
70% of’thc injected do$e and 2C0,‘n after 2 II. As shown 
in Table 11; compound CA-074 and pepstatin- 
a\ialof’ctuin ca~~sed little dela! in the degradation of en- 
docytosed FITC-asialofetuin in the li\er. In contrast, 
leupeptin strongly inhibited rhe digestion of’ FITC- 
asialofetuin and almost all the injected dew remained 
undigested e\‘cn 2 h after- the injection. 
Cathepsin I3 ft-otn mammalian liiet- displays both en- 
dopepridase and euopeptidasc acti\ ities, depending on 
the substrate [I ,2]. although highet- concentrations of 
cathepsin B at-e required to she\\ cndopeptidase activit) 
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than are necessary for dipeptidyl carboxypeptidase ac- 
tivity. Also, the fact that cathepsin I3 exists in lysosomes 
at very high concentrations [19] suggests that it might be 
expected to show potent endopeptidase activity in that 
location. But, the present investigation using com- 
Table 11 
pound CA-074, a selective cathepsin B inhibitor, reveal- 
ed that cathepsin B is not much involved in the degrada- 
tion of endogenous or exogenous proteins in lysosomes. 
Cathepsin D has limited action against native proteins, 
but considerable activity against denatured proteins, at 
pH 3.5-5. Our results indicating that the marked inhibi- 
tion of cathepsin D in liver lysosomes by injection of 
pepstatill-asiaiofetuin had no significatlt effect on 
iysosomal protein degradation suggest that like cathep- 
sin B, cathepsin D by itself cannot initiate protein 
breakdown in lysosomes. 
Administration of leupeptin, a potent cysteine pro- 
teinase inhibitor, causes an accumulation of auto- 
lysosomes in liver [ll] due to retarded digestion of se- 
questered proteins (Fig. 1) and endocytosed proteins 
(Table II). Since leupeptin is known to inhibit cathep- 
sins 13 and L strongly and cathepsin H much less (111 
and Table I), the results suggest that cathepsin H is less 
iInportant than cathepsins L and B in lysosomal pro- 
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teolysis. Cathepsin L is one of the most powerful 
lysosomal cysteine proteinases when assayed using pro- 
tein substrates [1,2], and it is thus a strong candidate as 
the initiator of protein breakdown in lysosomes. Since 
marked inhibition of lysosomal proteolysis by injection 
of leupeptin occurs as a result of blocking of not onl) 
cathepsin L but also other cysteine proteinascs, the 
identification of cathepsin L as the most important pro- 
tein in lysosomal protein breakdown must await the 
development of a selective inhibitor for cathepsin L in 
viva. 
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